nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenofovir—ABCC10—Gemcitabine—kidney cancer	0.12	0.183	CbGbCtD
Tenofovir—ABCC10—Paclitaxel—kidney cancer	0.108	0.165	CbGbCtD
Tenofovir—ABCC10—Vincristine—kidney cancer	0.0934	0.143	CbGbCtD
Tenofovir—ABCC10—Doxorubicin—kidney cancer	0.0584	0.0891	CbGbCtD
Tenofovir—ABCC4—Sorafenib—kidney cancer	0.0462	0.0705	CbGbCtD
Tenofovir—ABCC4—Sunitinib—kidney cancer	0.0375	0.0571	CbGbCtD
Tenofovir—ABCC2—Paclitaxel—kidney cancer	0.031	0.0472	CbGbCtD
Tenofovir—ABCC2—Sorafenib—kidney cancer	0.0275	0.042	CbGbCtD
Tenofovir—ABCC2—Vinblastine—kidney cancer	0.0272	0.0414	CbGbCtD
Tenofovir—ABCC2—Vincristine—kidney cancer	0.0267	0.0407	CbGbCtD
Tenofovir—ABCC2—Sunitinib—kidney cancer	0.0223	0.034	CbGbCtD
Tenofovir—CYP1A2—Pazopanib—kidney cancer	0.0177	0.027	CbGbCtD
Tenofovir—ABCC2—Doxorubicin—kidney cancer	0.0167	0.0255	CbGbCtD
Tenofovir—CYP1A2—Erlotinib—kidney cancer	0.0126	0.0192	CbGbCtD
Tenofovir—CYP1A2—Sorafenib—kidney cancer	0.0103	0.0156	CbGbCtD
Tenofovir—SLC22A8—nephron—kidney cancer	0.00553	0.0855	CbGeAlD
Tenofovir—SLC22A8—urine—kidney cancer	0.00444	0.0686	CbGeAlD
Tenofovir—AK2—cortex of kidney—kidney cancer	0.00354	0.0547	CbGeAlD
Tenofovir—AK4—nephron tubule—kidney cancer	0.00306	0.0473	CbGeAlD
Tenofovir—CYP1A2—urine—kidney cancer	0.00304	0.047	CbGeAlD
Tenofovir—NME1—renal system—kidney cancer	0.00288	0.0446	CbGeAlD
Tenofovir—NME1—kidney—kidney cancer	0.00279	0.0431	CbGeAlD
Tenofovir—AK4—renal system—kidney cancer	0.00278	0.043	CbGeAlD
Tenofovir—NME2—renal system—kidney cancer	0.00272	0.042	CbGeAlD
Tenofovir—AK4—kidney—kidney cancer	0.00269	0.0415	CbGeAlD
Tenofovir—AK4—cortex of kidney—kidney cancer	0.00262	0.0405	CbGeAlD
Tenofovir—AK4—gonad—kidney cancer	0.00249	0.0385	CbGeAlD
Tenofovir—AK4—cardiac atrium—kidney cancer	0.00249	0.0385	CbGeAlD
Tenofovir—Adenosine triphosphate—APAF1—kidney cancer	0.00247	0.468	CrCbGaD
Tenofovir—SLC22A6—nephron tubule—kidney cancer	0.00199	0.0308	CbGeAlD
Tenofovir—Adenosine monophosphate—APRT—kidney cancer	0.00184	0.348	CrCbGaD
Tenofovir—SLC22A6—cortex of kidney—kidney cancer	0.00171	0.0264	CbGeAlD
Tenofovir—ABCC10—renal system—kidney cancer	0.00132	0.0204	CbGeAlD
Tenofovir—ABCC10—kidney—kidney cancer	0.00127	0.0197	CbGeAlD
Tenofovir—ABCC10—cortex of kidney—kidney cancer	0.00124	0.0192	CbGeAlD
Tenofovir—ABCC4—nephron tubule—kidney cancer	0.0012	0.0186	CbGeAlD
Tenofovir—SLC22A8—nephron tubule—kidney cancer	0.00119	0.0185	CbGeAlD
Tenofovir—ABCC10—gonad—kidney cancer	0.00118	0.0183	CbGeAlD
Tenofovir—ABCC10—cardiac atrium—kidney cancer	0.00118	0.0183	CbGeAlD
Tenofovir—ABCC2—nephron tubule—kidney cancer	0.00116	0.018	CbGeAlD
Tenofovir—ABCC4—renal system—kidney cancer	0.00109	0.0169	CbGeAlD
Tenofovir—SLC22A8—renal system—kidney cancer	0.00109	0.0168	CbGeAlD
Tenofovir—ABCC2—renal system—kidney cancer	0.00106	0.0164	CbGeAlD
Tenofovir—ABCC4—kidney—kidney cancer	0.00106	0.0164	CbGeAlD
Tenofovir—SLC22A8—kidney—kidney cancer	0.00105	0.0162	CbGeAlD
Tenofovir—ABCC4—cortex of kidney—kidney cancer	0.00103	0.0159	CbGeAlD
Tenofovir—ABCC2—kidney—kidney cancer	0.00102	0.0158	CbGeAlD
Tenofovir—SLC22A8—cortex of kidney—kidney cancer	0.00102	0.0158	CbGeAlD
Tenofovir—ABCC2—cortex of kidney—kidney cancer	0.000997	0.0154	CbGeAlD
Tenofovir—NME1—Temsirolimus—Everolimus—kidney cancer	0.000941	0.2	CbGdCrCtD
Tenofovir—NME1—Sirolimus—Everolimus—kidney cancer	0.000941	0.2	CbGdCrCtD
Tenofovir—NME1—Sirolimus—Temsirolimus—kidney cancer	0.000941	0.2	CbGdCrCtD
Tenofovir—NME1—Everolimus—Temsirolimus—kidney cancer	0.000941	0.2	CbGdCrCtD
Tenofovir—NME1—Gefitinib—Erlotinib—kidney cancer	0.000938	0.199	CbGdCrCtD
Tenofovir—Adenosine triphosphate—ALK—kidney cancer	0.000861	0.163	CrCbGaD
Tenofovir—CYP1A2—renal system—kidney cancer	0.000743	0.0115	CbGeAlD
Tenofovir—Asthenia—Vinblastine—kidney cancer	0.000192	0.000961	CcSEcCtD
Tenofovir—Fatigue—Sunitinib—kidney cancer	0.000192	0.000961	CcSEcCtD
Tenofovir—Depression—Capecitabine—kidney cancer	0.000192	0.000961	CcSEcCtD
Tenofovir—Asthenia—Everolimus—kidney cancer	0.000191	0.000958	CcSEcCtD
Tenofovir—Pain—Sunitinib—kidney cancer	0.00019	0.000953	CcSEcCtD
Tenofovir—Immune system disorder—Paclitaxel—kidney cancer	0.00019	0.000952	CcSEcCtD
Tenofovir—Mediastinal disorder—Paclitaxel—kidney cancer	0.00019	0.00095	CcSEcCtD
Tenofovir—Gastrointestinal pain—Sorafenib—kidney cancer	0.000189	0.000947	CcSEcCtD
Tenofovir—Renal failure—Capecitabine—kidney cancer	0.000189	0.000947	CcSEcCtD
Tenofovir—Neuropathy peripheral—Capecitabine—kidney cancer	0.000189	0.000945	CcSEcCtD
Tenofovir—Pruritus—Everolimus—kidney cancer	0.000189	0.000944	CcSEcCtD
Tenofovir—Myalgia—Gemcitabine—kidney cancer	0.000186	0.000933	CcSEcCtD
Tenofovir—Arthralgia—Gemcitabine—kidney cancer	0.000186	0.000933	CcSEcCtD
Tenofovir—Chest pain—Gemcitabine—kidney cancer	0.000186	0.000933	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000185	0.000927	CcSEcCtD
Tenofovir—Nervous system disorder—Vincristine—kidney cancer	0.000185	0.000925	CcSEcCtD
Tenofovir—Asthenia—Erlotinib—kidney cancer	0.000184	0.000924	CcSEcCtD
Tenofovir—Mental disorder—Paclitaxel—kidney cancer	0.000184	0.000923	CcSEcCtD
Tenofovir—Haematuria—Capecitabine—kidney cancer	0.000183	0.000919	CcSEcCtD
Tenofovir—Malnutrition—Paclitaxel—kidney cancer	0.000183	0.000918	CcSEcCtD
Tenofovir—Decreased appetite—Dactinomycin—kidney cancer	0.000183	0.000917	CcSEcCtD
Tenofovir—Diarrhoea—Vinblastine—kidney cancer	0.000183	0.000917	CcSEcCtD
Tenofovir—Body temperature increased—Sorafenib—kidney cancer	0.000183	0.000916	CcSEcCtD
Tenofovir—Abdominal pain—Sorafenib—kidney cancer	0.000183	0.000916	CcSEcCtD
Tenofovir—Diarrhoea—Everolimus—kidney cancer	0.000182	0.000913	CcSEcCtD
Tenofovir—Gastrointestinal pain—Sunitinib—kidney cancer	0.000182	0.000912	CcSEcCtD
Tenofovir—Hyperhidrosis—Vincristine—kidney cancer	0.000182	0.000912	CcSEcCtD
Tenofovir—Hepatobiliary disease—Capecitabine—kidney cancer	0.000182	0.000911	CcSEcCtD
Tenofovir—Pruritus—Erlotinib—kidney cancer	0.000182	0.000911	CcSEcCtD
Tenofovir—Fatigue—Dactinomycin—kidney cancer	0.000182	0.00091	CcSEcCtD
Tenofovir—Flatulence—Paclitaxel—kidney cancer	0.000181	0.000904	CcSEcCtD
Tenofovir—Pain—Dactinomycin—kidney cancer	0.00018	0.000902	CcSEcCtD
Tenofovir—Anorexia—Vincristine—kidney cancer	0.000179	0.000899	CcSEcCtD
Tenofovir—Back pain—Paclitaxel—kidney cancer	0.000177	0.000888	CcSEcCtD
Tenofovir—Dizziness—Vinblastine—kidney cancer	0.000177	0.000886	CcSEcCtD
Tenofovir—Dizziness—Everolimus—kidney cancer	0.000176	0.000883	CcSEcCtD
Tenofovir—Abdominal pain—Sunitinib—kidney cancer	0.000176	0.000881	CcSEcCtD
Tenofovir—Body temperature increased—Sunitinib—kidney cancer	0.000176	0.000881	CcSEcCtD
Tenofovir—Diarrhoea—Erlotinib—kidney cancer	0.000176	0.000881	CcSEcCtD
Tenofovir—Nervous system disorder—Gemcitabine—kidney cancer	0.000175	0.000877	CcSEcCtD
Tenofovir—Renal failure acute—Doxorubicin—kidney cancer	0.000174	0.000873	CcSEcCtD
Tenofovir—Skin disorder—Gemcitabine—kidney cancer	0.000173	0.000869	CcSEcCtD
Tenofovir—Hepatitis—Capecitabine—kidney cancer	0.000173	0.000865	CcSEcCtD
Tenofovir—Hyperhidrosis—Gemcitabine—kidney cancer	0.000173	0.000865	CcSEcCtD
Tenofovir—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000172	0.000863	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000172	0.000859	CcSEcCtD
Tenofovir—Urinary tract disorder—Capecitabine—kidney cancer	0.000171	0.000854	CcSEcCtD
Tenofovir—Hypersensitivity—Sorafenib—kidney cancer	0.00017	0.000854	CcSEcCtD
Tenofovir—Insomnia—Vincristine—kidney cancer	0.00017	0.000853	CcSEcCtD
Tenofovir—Anorexia—Gemcitabine—kidney cancer	0.00017	0.000853	CcSEcCtD
Tenofovir—Vomiting—Vinblastine—kidney cancer	0.00017	0.000852	CcSEcCtD
Tenofovir—Dizziness—Erlotinib—kidney cancer	0.00017	0.000852	CcSEcCtD
Tenofovir—Connective tissue disorder—Capecitabine—kidney cancer	0.00017	0.00085	CcSEcCtD
Tenofovir—Vomiting—Everolimus—kidney cancer	0.000169	0.000849	CcSEcCtD
Tenofovir—Urethral disorder—Capecitabine—kidney cancer	0.000169	0.000848	CcSEcCtD
Tenofovir—Renal impairment—Doxorubicin—kidney cancer	0.000169	0.000847	CcSEcCtD
Tenofovir—Rash—Everolimus—kidney cancer	0.000168	0.000841	CcSEcCtD
Tenofovir—Dermatitis—Everolimus—kidney cancer	0.000168	0.000841	CcSEcCtD
Tenofovir—Headache—Vinblastine—kidney cancer	0.000168	0.000839	CcSEcCtD
Tenofovir—Angioedema—Paclitaxel—kidney cancer	0.000167	0.000838	CcSEcCtD
Tenofovir—Headache—Everolimus—kidney cancer	0.000167	0.000836	CcSEcCtD
Tenofovir—Body temperature increased—Dactinomycin—kidney cancer	0.000167	0.000834	CcSEcCtD
Tenofovir—Abdominal pain—Dactinomycin—kidney cancer	0.000167	0.000834	CcSEcCtD
Tenofovir—Asthenia—Sorafenib—kidney cancer	0.000166	0.000831	CcSEcCtD
Tenofovir—Hypersensitivity—Sunitinib—kidney cancer	0.000164	0.000821	CcSEcCtD
Tenofovir—Decreased appetite—Vincristine—kidney cancer	0.000164	0.00082	CcSEcCtD
Tenofovir—Pruritus—Sorafenib—kidney cancer	0.000164	0.00082	CcSEcCtD
Tenofovir—Vomiting—Erlotinib—kidney cancer	0.000163	0.000819	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000163	0.000815	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Vincristine—kidney cancer	0.000163	0.000814	CcSEcCtD
Tenofovir—Fatigue—Vincristine—kidney cancer	0.000162	0.000813	CcSEcCtD
Tenofovir—Rash—Erlotinib—kidney cancer	0.000162	0.000812	CcSEcCtD
Tenofovir—Dermatitis—Erlotinib—kidney cancer	0.000162	0.000811	CcSEcCtD
Tenofovir—Insomnia—Gemcitabine—kidney cancer	0.000162	0.000809	CcSEcCtD
Tenofovir—Headache—Erlotinib—kidney cancer	0.000161	0.000807	CcSEcCtD
Tenofovir—Pain—Vincristine—kidney cancer	0.000161	0.000806	CcSEcCtD
Tenofovir—Asthenia—Sunitinib—kidney cancer	0.00016	0.0008	CcSEcCtD
Tenofovir—Dyspnoea—Gemcitabine—kidney cancer	0.000159	0.000797	CcSEcCtD
Tenofovir—Nausea—Vinblastine—kidney cancer	0.000159	0.000796	CcSEcCtD
Tenofovir—Nausea—Everolimus—kidney cancer	0.000158	0.000793	CcSEcCtD
Tenofovir—Diarrhoea—Sorafenib—kidney cancer	0.000158	0.000793	CcSEcCtD
Tenofovir—Pruritus—Sunitinib—kidney cancer	0.000157	0.000789	CcSEcCtD
Tenofovir—Immune system disorder—Capecitabine—kidney cancer	0.000156	0.000781	CcSEcCtD
Tenofovir—Arthralgia—Paclitaxel—kidney cancer	0.000156	0.000781	CcSEcCtD
Tenofovir—Chest pain—Paclitaxel—kidney cancer	0.000156	0.000781	CcSEcCtD
Tenofovir—Myalgia—Paclitaxel—kidney cancer	0.000156	0.000781	CcSEcCtD
Tenofovir—Mediastinal disorder—Capecitabine—kidney cancer	0.000156	0.00078	CcSEcCtD
Tenofovir—Anxiety—Paclitaxel—kidney cancer	0.000155	0.000779	CcSEcCtD
Tenofovir—Decreased appetite—Gemcitabine—kidney cancer	0.000155	0.000778	CcSEcCtD
Tenofovir—Hypersensitivity—Dactinomycin—kidney cancer	0.000155	0.000778	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000155	0.000776	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000154	0.000772	CcSEcCtD
Tenofovir—Fatigue—Gemcitabine—kidney cancer	0.000154	0.000771	CcSEcCtD
Tenofovir—Gastrointestinal pain—Vincristine—kidney cancer	0.000154	0.000771	CcSEcCtD
Tenofovir—Dizziness—Sorafenib—kidney cancer	0.000153	0.000766	CcSEcCtD
Tenofovir—Pain—Gemcitabine—kidney cancer	0.000153	0.000765	CcSEcCtD
Tenofovir—Nausea—Erlotinib—kidney cancer	0.000153	0.000765	CcSEcCtD
Tenofovir—Diarrhoea—Sunitinib—kidney cancer	0.000152	0.000763	CcSEcCtD
Tenofovir—Mental disorder—Capecitabine—kidney cancer	0.000151	0.000758	CcSEcCtD
Tenofovir—Asthenia—Dactinomycin—kidney cancer	0.000151	0.000757	CcSEcCtD
Tenofovir—Blood creatinine increased—Doxorubicin—kidney cancer	0.000151	0.000755	CcSEcCtD
Tenofovir—Malnutrition—Capecitabine—kidney cancer	0.00015	0.000753	CcSEcCtD
Tenofovir—Abdominal pain—Vincristine—kidney cancer	0.000149	0.000745	CcSEcCtD
Tenofovir—Body temperature increased—Vincristine—kidney cancer	0.000149	0.000745	CcSEcCtD
Tenofovir—Flatulence—Capecitabine—kidney cancer	0.000148	0.000742	CcSEcCtD
Tenofovir—Dizziness—Sunitinib—kidney cancer	0.000147	0.000737	CcSEcCtD
Tenofovir—Vomiting—Sorafenib—kidney cancer	0.000147	0.000737	CcSEcCtD
Tenofovir—Nervous system disorder—Paclitaxel—kidney cancer	0.000147	0.000734	CcSEcCtD
Tenofovir—Hypokalaemia—Doxorubicin—kidney cancer	0.000146	0.000734	CcSEcCtD
Tenofovir—Rash—Sorafenib—kidney cancer	0.000146	0.00073	CcSEcCtD
Tenofovir—Dermatitis—Sorafenib—kidney cancer	0.000146	0.00073	CcSEcCtD
Tenofovir—Back pain—Capecitabine—kidney cancer	0.000145	0.000728	CcSEcCtD
Tenofovir—Skin disorder—Paclitaxel—kidney cancer	0.000145	0.000727	CcSEcCtD
Tenofovir—Headache—Sorafenib—kidney cancer	0.000145	0.000726	CcSEcCtD
Tenofovir—Hyperhidrosis—Paclitaxel—kidney cancer	0.000145	0.000724	CcSEcCtD
Tenofovir—Diarrhoea—Dactinomycin—kidney cancer	0.000144	0.000722	CcSEcCtD
Tenofovir—Nasopharyngitis—Doxorubicin—kidney cancer	0.000144	0.000721	CcSEcCtD
Tenofovir—Anorexia—Paclitaxel—kidney cancer	0.000143	0.000714	CcSEcCtD
Tenofovir—Muscular weakness—Doxorubicin—kidney cancer	0.000142	0.000711	CcSEcCtD
Tenofovir—SLC22A6—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000142	0.00202	CbGpPWpGaD
Tenofovir—Vomiting—Sunitinib—kidney cancer	0.000142	0.000709	CcSEcCtD
Tenofovir—Body temperature increased—Gemcitabine—kidney cancer	0.000141	0.000707	CcSEcCtD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000141	0.00201	CbGpPWpGaD
Tenofovir—Rash—Sunitinib—kidney cancer	0.00014	0.000703	CcSEcCtD
Tenofovir—Dermatitis—Sunitinib—kidney cancer	0.00014	0.000702	CcSEcCtD
Tenofovir—Headache—Sunitinib—kidney cancer	0.000139	0.000698	CcSEcCtD
Tenofovir—Hypersensitivity—Vincristine—kidney cancer	0.000139	0.000695	CcSEcCtD
Tenofovir—Nausea—Sorafenib—kidney cancer	0.000137	0.000688	CcSEcCtD
Tenofovir—NME1—Metabolism—PPAT—kidney cancer	0.000136	0.00195	CbGpPWpGaD
Tenofovir—NME2—Metabolism—SLC5A3—kidney cancer	0.000136	0.00195	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GLIPR1—kidney cancer	0.000136	0.00195	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PGK1—kidney cancer	0.000136	0.00195	CbGpPWpGaD
Tenofovir—Pancreatitis—Doxorubicin—kidney cancer	0.000136	0.000683	CcSEcCtD
Tenofovir—CYP1A2—Biological oxidations—ACY1—kidney cancer	0.000136	0.00195	CbGpPWpGaD
Tenofovir—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000136	0.000682	CcSEcCtD
Tenofovir—ABCC4—NRF2 pathway—SLC5A5—kidney cancer	0.000136	0.00195	CbGpPWpGaD
Tenofovir—Insomnia—Paclitaxel—kidney cancer	0.000135	0.000677	CcSEcCtD
Tenofovir—Asthenia—Vincristine—kidney cancer	0.000135	0.000676	CcSEcCtD
Tenofovir—Vomiting—Dactinomycin—kidney cancer	0.000134	0.000671	CcSEcCtD
Tenofovir—NME2—Metabolism—LDHB—kidney cancer	0.000134	0.00191	CbGpPWpGaD
Tenofovir—Dyspnoea—Paclitaxel—kidney cancer	0.000133	0.000668	CcSEcCtD
Tenofovir—Rash—Dactinomycin—kidney cancer	0.000133	0.000665	CcSEcCtD
Tenofovir—AK2—Metabolism—ITPR2—kidney cancer	0.000132	0.00189	CbGpPWpGaD
Tenofovir—Nausea—Sunitinib—kidney cancer	0.000132	0.000662	CcSEcCtD
Tenofovir—Dyspepsia—Paclitaxel—kidney cancer	0.000132	0.000659	CcSEcCtD
Tenofovir—ABCC4—NRF2 pathway—SLC2A1—kidney cancer	0.000131	0.00188	CbGpPWpGaD
Tenofovir—Decreased appetite—Paclitaxel—kidney cancer	0.00013	0.000651	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000129	0.000647	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000129	0.000647	CcSEcCtD
Tenofovir—Fatigue—Paclitaxel—kidney cancer	0.000129	0.000646	CcSEcCtD
Tenofovir—Diarrhoea—Vincristine—kidney cancer	0.000129	0.000645	CcSEcCtD
Tenofovir—Asthenia—Gemcitabine—kidney cancer	0.000128	0.000642	CcSEcCtD
Tenofovir—Myalgia—Capecitabine—kidney cancer	0.000128	0.000641	CcSEcCtD
Tenofovir—Arthralgia—Capecitabine—kidney cancer	0.000128	0.000641	CcSEcCtD
Tenofovir—Chest pain—Capecitabine—kidney cancer	0.000128	0.000641	CcSEcCtD
Tenofovir—Pain—Paclitaxel—kidney cancer	0.000128	0.00064	CcSEcCtD
Tenofovir—Anxiety—Capecitabine—kidney cancer	0.000128	0.000639	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000127	0.000637	CcSEcCtD
Tenofovir—NME1—Metabolism—APRT—kidney cancer	0.000127	0.00181	CbGpPWpGaD
Tenofovir—NME1—Metabolism—FH—kidney cancer	0.000127	0.00181	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	0.000127	0.00181	CbGpPWpGaD
Tenofovir—Pruritus—Gemcitabine—kidney cancer	0.000126	0.000633	CcSEcCtD
Tenofovir—ABCC4—Hemostasis—L1CAM—kidney cancer	0.000126	0.0018	CbGpPWpGaD
Tenofovir—Weight decreased—Doxorubicin—kidney cancer	0.000126	0.00063	CcSEcCtD
Tenofovir—Hyperglycaemia—Doxorubicin—kidney cancer	0.000125	0.000628	CcSEcCtD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000125	0.00179	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	0.000125	0.00179	CbGpPWpGaD
Tenofovir—Nausea—Dactinomycin—kidney cancer	0.000125	0.000627	CcSEcCtD
Tenofovir—Pneumonia—Doxorubicin—kidney cancer	0.000125	0.000625	CcSEcCtD
Tenofovir—Dizziness—Vincristine—kidney cancer	0.000125	0.000624	CcSEcCtD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—ITPR2—kidney cancer	0.000124	0.00178	CbGpPWpGaD
Tenofovir—Infestation NOS—Doxorubicin—kidney cancer	0.000124	0.000621	CcSEcCtD
Tenofovir—Infestation—Doxorubicin—kidney cancer	0.000124	0.000621	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	0.000122	0.00175	CbGpPWpGaD
Tenofovir—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000122	0.000612	CcSEcCtD
Tenofovir—Diarrhoea—Gemcitabine—kidney cancer	0.000122	0.000612	CcSEcCtD
Tenofovir—ABCC4—NRF2 pathway—EGR1—kidney cancer	0.000122	0.00174	CbGpPWpGaD
Tenofovir—Renal failure—Doxorubicin—kidney cancer	0.000122	0.000611	CcSEcCtD
Tenofovir—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000122	0.000609	CcSEcCtD
Tenofovir—ABCC2—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000121	0.00173	CbGpPWpGaD
Tenofovir—AK2—Metabolism—ACHE—kidney cancer	0.000121	0.00172	CbGpPWpGaD
Tenofovir—AK2—Metabolism—GSTT1—kidney cancer	0.000121	0.00172	CbGpPWpGaD
Tenofovir—Nervous system disorder—Capecitabine—kidney cancer	0.00012	0.000603	CcSEcCtD
Tenofovir—ABCC10—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.00012	0.00171	CbGpPWpGaD
Tenofovir—Vomiting—Vincristine—kidney cancer	0.00012	0.000599	CcSEcCtD
Tenofovir—NME1—Metabolism—GPC3—kidney cancer	0.000119	0.0017	CbGpPWpGaD
Tenofovir—Skin disorder—Capecitabine—kidney cancer	0.000119	0.000597	CcSEcCtD
Tenofovir—Sweating—Doxorubicin—kidney cancer	0.000119	0.000595	CcSEcCtD
Tenofovir—Rash—Vincristine—kidney cancer	0.000119	0.000594	CcSEcCtD
Tenofovir—Hyperhidrosis—Capecitabine—kidney cancer	0.000119	0.000594	CcSEcCtD
Tenofovir—Dermatitis—Vincristine—kidney cancer	0.000119	0.000594	CcSEcCtD
Tenofovir—Haematuria—Doxorubicin—kidney cancer	0.000118	0.000592	CcSEcCtD
Tenofovir—Abdominal pain—Paclitaxel—kidney cancer	0.000118	0.000592	CcSEcCtD
Tenofovir—Body temperature increased—Paclitaxel—kidney cancer	0.000118	0.000592	CcSEcCtD
Tenofovir—Headache—Vincristine—kidney cancer	0.000118	0.000591	CcSEcCtD
Tenofovir—Adenosine triphosphate—ABCB1—kidney cancer	0.000117	0.0222	CrCbGaD
Tenofovir—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000117	0.000587	CcSEcCtD
Tenofovir—Anorexia—Capecitabine—kidney cancer	0.000117	0.000586	CcSEcCtD
Tenofovir—Sinusitis—Doxorubicin—kidney cancer	0.000116	0.000583	CcSEcCtD
Tenofovir—NME2—Metabolism—CA9—kidney cancer	0.000116	0.00166	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CA2—kidney cancer	0.000116	0.00166	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	0.000116	0.00166	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000116	0.00165	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—SLC5A5—kidney cancer	0.000115	0.00164	CbGpPWpGaD
Tenofovir—AK2—Metabolism—SCARB1—kidney cancer	0.000114	0.00163	CbGpPWpGaD
Tenofovir—Vomiting—Gemcitabine—kidney cancer	0.000114	0.000569	CcSEcCtD
Tenofovir—AK2—Metabolism—PTGS1—kidney cancer	0.000113	0.00162	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ALAD—kidney cancer	0.000113	0.00162	CbGpPWpGaD
Tenofovir—Rash—Gemcitabine—kidney cancer	0.000113	0.000564	CcSEcCtD
Tenofovir—Dermatitis—Gemcitabine—kidney cancer	0.000113	0.000563	CcSEcCtD
Tenofovir—CYP1A2—Estrogen Receptor Pathway—JUN—kidney cancer	0.000112	0.0016	CbGpPWpGaD
Tenofovir—Headache—Gemcitabine—kidney cancer	0.000112	0.00056	CcSEcCtD
Tenofovir—Nausea—Vincristine—kidney cancer	0.000112	0.00056	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000112	0.00056	CcSEcCtD
Tenofovir—Hepatitis—Doxorubicin—kidney cancer	0.000111	0.000558	CcSEcCtD
Tenofovir—ABCC4—Fluoropyrimidine Activity—TP53—kidney cancer	0.000111	0.00159	CbGpPWpGaD
Tenofovir—Insomnia—Capecitabine—kidney cancer	0.000111	0.000556	CcSEcCtD
Tenofovir—AK2—Metabolism—PSMD7—kidney cancer	0.000111	0.00158	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—SLC2A1—kidney cancer	0.000111	0.00158	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	0.000111	0.00158	CbGpPWpGaD
Tenofovir—CYP1A2—Arachidonic acid metabolism—PTGS1—kidney cancer	0.000111	0.00158	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ST3GAL2—kidney cancer	0.00011	0.00158	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	0.00011	0.00158	CbGpPWpGaD
Tenofovir—Hypersensitivity—Paclitaxel—kidney cancer	0.00011	0.000552	CcSEcCtD
Tenofovir—CYP1A2—Melatonin metabolism and effects—CYP1A1—kidney cancer	0.00011	0.00157	CbGpPWpGaD
Tenofovir—Urinary tract disorder—Doxorubicin—kidney cancer	0.00011	0.000551	CcSEcCtD
Tenofovir—ABCC4—NRF2 pathway—GSTP1—kidney cancer	0.00011	0.00157	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	0.00011	0.00157	CbGpPWpGaD
Tenofovir—Connective tissue disorder—Doxorubicin—kidney cancer	0.000109	0.000548	CcSEcCtD
Tenofovir—Dyspnoea—Capecitabine—kidney cancer	0.000109	0.000548	CcSEcCtD
Tenofovir—Urethral disorder—Doxorubicin—kidney cancer	0.000109	0.000547	CcSEcCtD
Tenofovir—Dyspepsia—Capecitabine—kidney cancer	0.000108	0.000541	CcSEcCtD
Tenofovir—NME1—Metabolism—ALDH1A1—kidney cancer	0.000108	0.00154	CbGpPWpGaD
Tenofovir—Asthenia—Paclitaxel—kidney cancer	0.000107	0.000537	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	0.000107	0.00153	CbGpPWpGaD
Tenofovir—Decreased appetite—Capecitabine—kidney cancer	0.000107	0.000534	CcSEcCtD
Tenofovir—Nausea—Gemcitabine—kidney cancer	0.000106	0.000531	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000106	0.000531	CcSEcCtD
Tenofovir—Fatigue—Capecitabine—kidney cancer	0.000106	0.00053	CcSEcCtD
Tenofovir—Pruritus—Paclitaxel—kidney cancer	0.000106	0.00053	CcSEcCtD
Tenofovir—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000105	0.00151	CbGpPWpGaD
Tenofovir—AK2—Metabolism—BCHE—kidney cancer	0.000105	0.0015	CbGpPWpGaD
Tenofovir—Pain—Capecitabine—kidney cancer	0.000105	0.000526	CcSEcCtD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUNB—kidney cancer	0.000104	0.00149	CbGpPWpGaD
Tenofovir—AK2—Metabolism—SLC5A5—kidney cancer	0.000104	0.00148	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PGK1—kidney cancer	0.000103	0.00148	CbGpPWpGaD
Tenofovir—NME1—Metabolism—SLC5A3—kidney cancer	0.000103	0.00148	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—EGR1—kidney cancer	0.000103	0.00147	CbGpPWpGaD
Tenofovir—Diarrhoea—Paclitaxel—kidney cancer	0.000102	0.000512	CcSEcCtD
Tenofovir—NME1—Metabolism—LDHB—kidney cancer	0.000101	0.00145	CbGpPWpGaD
Tenofovir—ABCC4—NRF2 pathway—GSTM1—kidney cancer	0.000101	0.00144	CbGpPWpGaD
Tenofovir—Immune system disorder—Doxorubicin—kidney cancer	0.000101	0.000504	CcSEcCtD
Tenofovir—Gastrointestinal pain—Capecitabine—kidney cancer	0.0001	0.000503	CcSEcCtD
Tenofovir—Mediastinal disorder—Doxorubicin—kidney cancer	0.0001	0.000503	CcSEcCtD
Tenofovir—AK2—Metabolism—SLC2A1—kidney cancer	0.0001	0.00143	CbGpPWpGaD
Tenofovir—Dizziness—Paclitaxel—kidney cancer	9.89e-05	0.000495	CcSEcCtD
Tenofovir—NME2—Metabolism—CRABP1—kidney cancer	9.87e-05	0.00141	CbGpPWpGaD
Tenofovir—Mental disorder—Doxorubicin—kidney cancer	9.76e-05	0.000489	CcSEcCtD
Tenofovir—Abdominal pain—Capecitabine—kidney cancer	9.7e-05	0.000486	CcSEcCtD
Tenofovir—Body temperature increased—Capecitabine—kidney cancer	9.7e-05	0.000486	CcSEcCtD
Tenofovir—Malnutrition—Doxorubicin—kidney cancer	9.69e-05	0.000485	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	9.64e-05	0.00138	CbGpPWpGaD
Tenofovir—Flatulence—Doxorubicin—kidney cancer	9.55e-05	0.000478	CcSEcCtD
Tenofovir—ABCC4—Hemostasis—ANXA2—kidney cancer	9.55e-05	0.00136	CbGpPWpGaD
Tenofovir—Vomiting—Paclitaxel—kidney cancer	9.51e-05	0.000476	CcSEcCtD
Tenofovir—Rash—Paclitaxel—kidney cancer	9.43e-05	0.000472	CcSEcCtD
Tenofovir—Dermatitis—Paclitaxel—kidney cancer	9.42e-05	0.000472	CcSEcCtD
Tenofovir—Back pain—Doxorubicin—kidney cancer	9.38e-05	0.00047	CcSEcCtD
Tenofovir—Headache—Paclitaxel—kidney cancer	9.37e-05	0.000469	CcSEcCtD
Tenofovir—ABCC2—NRF2 pathway—GSTP1—kidney cancer	9.25e-05	0.00132	CbGpPWpGaD
Tenofovir—NME2—Metabolism—ITPR2—kidney cancer	9.17e-05	0.00131	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—ABCB1—kidney cancer	9.13e-05	0.0013	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	9.12e-05	0.0013	CbGpPWpGaD
Tenofovir—Hypersensitivity—Capecitabine—kidney cancer	9.04e-05	0.000453	CcSEcCtD
Tenofovir—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	8.95e-05	0.00128	CbGpPWpGaD
Tenofovir—Nausea—Paclitaxel—kidney cancer	8.88e-05	0.000445	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	8.87e-05	0.00127	CbGpPWpGaD
Tenofovir—Asthenia—Capecitabine—kidney cancer	8.81e-05	0.000441	CcSEcCtD
Tenofovir—NME1—Metabolism—CA9—kidney cancer	8.79e-05	0.00126	CbGpPWpGaD
Tenofovir—Pruritus—Capecitabine—kidney cancer	8.68e-05	0.000435	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	8.68e-05	0.00124	CbGpPWpGaD
Tenofovir—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	8.64e-05	0.00123	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—ATP7B—kidney cancer	8.62e-05	0.00123	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—SLC5A3—kidney cancer	8.62e-05	0.00123	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—ANXA2—kidney cancer	8.62e-05	0.00123	CbGpPWpGaD
Tenofovir—ABCC2—NRF2 pathway—GSTM1—kidney cancer	8.5e-05	0.00121	CbGpPWpGaD
Tenofovir—Diarrhoea—Capecitabine—kidney cancer	8.4e-05	0.00042	CcSEcCtD
Tenofovir—NME2—Metabolism—GSTT1—kidney cancer	8.36e-05	0.0012	CbGpPWpGaD
Tenofovir—AK2—Metabolism—GSTP1—kidney cancer	8.36e-05	0.0012	CbGpPWpGaD
Tenofovir—NME2—Metabolism—ACHE—kidney cancer	8.36e-05	0.0012	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—SLC5A3—kidney cancer	8.27e-05	0.00118	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—ATP7B—kidney cancer	8.27e-05	0.00118	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—ANXA2—kidney cancer	8.27e-05	0.00118	CbGpPWpGaD
Tenofovir—Arthralgia—Doxorubicin—kidney cancer	8.25e-05	0.000413	CcSEcCtD
Tenofovir—Chest pain—Doxorubicin—kidney cancer	8.25e-05	0.000413	CcSEcCtD
Tenofovir—Myalgia—Doxorubicin—kidney cancer	8.25e-05	0.000413	CcSEcCtD
Tenofovir—Anxiety—Doxorubicin—kidney cancer	8.22e-05	0.000412	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	8.2e-05	0.00117	CbGpPWpGaD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	8.2e-05	0.00041	CcSEcCtD
Tenofovir—Dizziness—Capecitabine—kidney cancer	8.12e-05	0.000406	CcSEcCtD
Tenofovir—AK2—Metabolism—ABCB1—kidney cancer	7.92e-05	0.00113	CbGpPWpGaD
Tenofovir—NME2—Metabolism—SCARB1—kidney cancer	7.92e-05	0.00113	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—KCNMA1—kidney cancer	7.91e-05	0.00113	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PTGS1—kidney cancer	7.84e-05	0.00112	CbGpPWpGaD
Tenofovir—Vomiting—Capecitabine—kidney cancer	7.8e-05	0.000391	CcSEcCtD
Tenofovir—Nervous system disorder—Doxorubicin—kidney cancer	7.76e-05	0.000388	CcSEcCtD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	7.75e-05	0.00111	CbGpPWpGaD
Tenofovir—Rash—Capecitabine—kidney cancer	7.74e-05	0.000387	CcSEcCtD
Tenofovir—Dermatitis—Capecitabine—kidney cancer	7.73e-05	0.000387	CcSEcCtD
Tenofovir—Headache—Capecitabine—kidney cancer	7.69e-05	0.000385	CcSEcCtD
Tenofovir—AK2—Metabolism—GSTM1—kidney cancer	7.69e-05	0.0011	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PSMD7—kidney cancer	7.69e-05	0.0011	CbGpPWpGaD
Tenofovir—Skin disorder—Doxorubicin—kidney cancer	7.68e-05	0.000385	CcSEcCtD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—IGF2—kidney cancer	7.66e-05	0.00109	CbGpPWpGaD
Tenofovir—Hyperhidrosis—Doxorubicin—kidney cancer	7.65e-05	0.000383	CcSEcCtD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—kidney cancer	7.62e-05	0.00109	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—kidney cancer	7.62e-05	0.00109	CbGpPWpGaD
Tenofovir—CYP1A2—Tryptophan metabolism—CYP1A1—kidney cancer	7.62e-05	0.00109	CbGpPWpGaD
Tenofovir—Anorexia—Doxorubicin—kidney cancer	7.54e-05	0.000378	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	7.53e-05	0.00108	CbGpPWpGaD
Tenofovir—CYP1A2—Phase II conjugation—GSTT1—kidney cancer	7.51e-05	0.00107	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CRABP1—kidney cancer	7.48e-05	0.00107	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—ALDH1A1—kidney cancer	7.47e-05	0.00107	CbGpPWpGaD
Tenofovir—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	7.47e-05	0.00107	CbGpPWpGaD
Tenofovir—Nausea—Capecitabine—kidney cancer	7.29e-05	0.000365	CcSEcCtD
Tenofovir—AK2—Metabolism—CYP1A1—kidney cancer	7.29e-05	0.00104	CbGpPWpGaD
Tenofovir—NME2—Metabolism—BCHE—kidney cancer	7.29e-05	0.00104	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	7.29e-05	0.00104	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—VEGFA—kidney cancer	7.24e-05	0.00103	CbGpPWpGaD
Tenofovir—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	7.21e-05	0.00103	CbGpPWpGaD
Tenofovir—Musculoskeletal discomfort—Doxorubicin—kidney cancer	7.21e-05	0.000361	CcSEcCtD
Tenofovir—NME2—Metabolism—SLC5A5—kidney cancer	7.2e-05	0.00103	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—ANXA2—kidney cancer	7.19e-05	0.00103	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC5A3—kidney cancer	7.19e-05	0.00103	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—ATP7B—kidney cancer	7.19e-05	0.00103	CbGpPWpGaD
Tenofovir—Insomnia—Doxorubicin—kidney cancer	7.15e-05	0.000358	CcSEcCtD
Tenofovir—CYP1A2—Arachidonic acid metabolism—CYP1A1—kidney cancer	7.12e-05	0.00102	CbGpPWpGaD
Tenofovir—Dyspnoea—Doxorubicin—kidney cancer	7.05e-05	0.000353	CcSEcCtD
Tenofovir—ABCC2—Transmembrane transport of small molecules—ATP7B—kidney cancer	6.97e-05	0.000996	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—ANXA2—kidney cancer	6.97e-05	0.000996	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	6.97e-05	0.000996	CbGpPWpGaD
Tenofovir—Dyspepsia—Doxorubicin—kidney cancer	6.96e-05	0.000349	CcSEcCtD
Tenofovir—NME1—Metabolism—ITPR2—kidney cancer	6.95e-05	0.000993	CbGpPWpGaD
Tenofovir—NME2—Metabolism—SLC2A1—kidney cancer	6.95e-05	0.000993	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—GRB7—kidney cancer	6.9e-05	0.000986	CbGpPWpGaD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—kidney cancer	6.9e-05	0.000986	CbGpPWpGaD
Tenofovir—Decreased appetite—Doxorubicin—kidney cancer	6.88e-05	0.000344	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Doxorubicin—kidney cancer	6.83e-05	0.000342	CcSEcCtD
Tenofovir—Fatigue—Doxorubicin—kidney cancer	6.82e-05	0.000342	CcSEcCtD
Tenofovir—Pain—Doxorubicin—kidney cancer	6.76e-05	0.000339	CcSEcCtD
Tenofovir—Gastrointestinal pain—Doxorubicin—kidney cancer	6.47e-05	0.000324	CcSEcCtD
Tenofovir—ABCC4—Hemostasis—ITPR2—kidney cancer	6.42e-05	0.000917	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ACHE—kidney cancer	6.34e-05	0.000906	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GSTT1—kidney cancer	6.34e-05	0.000906	CbGpPWpGaD
Tenofovir—Abdominal pain—Doxorubicin—kidney cancer	6.25e-05	0.000313	CcSEcCtD
Tenofovir—Body temperature increased—Doxorubicin—kidney cancer	6.25e-05	0.000313	CcSEcCtD
Tenofovir—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	6.16e-05	0.00088	CbGpPWpGaD
Tenofovir—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	6.08e-05	0.000868	CbGpPWpGaD
Tenofovir—NME1—Metabolism—SCARB1—kidney cancer	6e-05	0.000858	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PTGS1—kidney cancer	5.94e-05	0.000849	CbGpPWpGaD
Tenofovir—Hypersensitivity—Doxorubicin—kidney cancer	5.83e-05	0.000292	CcSEcCtD
Tenofovir—NME1—Metabolism—PSMD7—kidney cancer	5.83e-05	0.000832	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GSTP1—kidney cancer	5.8e-05	0.000829	CbGpPWpGaD
Tenofovir—Asthenia—Doxorubicin—kidney cancer	5.68e-05	0.000284	CcSEcCtD
Tenofovir—Pruritus—Doxorubicin—kidney cancer	5.6e-05	0.00028	CcSEcCtD
Tenofovir—NME1—Metabolism—BCHE—kidney cancer	5.52e-05	0.000789	CbGpPWpGaD
Tenofovir—NME2—Metabolism—ABCB1—kidney cancer	5.49e-05	0.000784	CbGpPWpGaD
Tenofovir—NME1—Metabolism—SLC5A5—kidney cancer	5.45e-05	0.00078	CbGpPWpGaD
Tenofovir—AK2—Metabolism—POMC—kidney cancer	5.43e-05	0.000776	CbGpPWpGaD
Tenofovir—Diarrhoea—Doxorubicin—kidney cancer	5.41e-05	0.000271	CcSEcCtD
Tenofovir—NME2—Metabolism—GSTM1—kidney cancer	5.33e-05	0.000761	CbGpPWpGaD
Tenofovir—ABCC4—Ectoderm Differentiation—CTNNB1—kidney cancer	5.32e-05	0.00076	CbGpPWpGaD
Tenofovir—NME1—Metabolism—SLC2A1—kidney cancer	5.27e-05	0.000753	CbGpPWpGaD
Tenofovir—Dizziness—Doxorubicin—kidney cancer	5.23e-05	0.000262	CcSEcCtD
Tenofovir—CYP1A2—Phase II conjugation—GSTP1—kidney cancer	5.2e-05	0.000744	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—RAF1—kidney cancer	5.16e-05	0.000738	CbGpPWpGaD
Tenofovir—NME2—Metabolism—CYP1A1—kidney cancer	5.05e-05	0.000722	CbGpPWpGaD
Tenofovir—Vomiting—Doxorubicin—kidney cancer	5.03e-05	0.000252	CcSEcCtD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	4.99e-05	0.000713	CbGpPWpGaD
Tenofovir—Rash—Doxorubicin—kidney cancer	4.99e-05	0.00025	CcSEcCtD
Tenofovir—Dermatitis—Doxorubicin—kidney cancer	4.98e-05	0.00025	CcSEcCtD
Tenofovir—Headache—Doxorubicin—kidney cancer	4.96e-05	0.000248	CcSEcCtD
Tenofovir—CYP1A2—Phase II conjugation—GSTM1—kidney cancer	4.78e-05	0.000683	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IFNA1—kidney cancer	4.71e-05	0.000673	CbGpPWpGaD
Tenofovir—Nausea—Doxorubicin—kidney cancer	4.7e-05	0.000235	CcSEcCtD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—kidney cancer	4.68e-05	0.000669	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—RELA—kidney cancer	4.66e-05	0.000666	CbGpPWpGaD
Tenofovir—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	4.59e-05	0.000656	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—SLC5A5—kidney cancer	4.55e-05	0.00065	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—kidney cancer	4.53e-05	0.000647	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GSTP1—kidney cancer	4.39e-05	0.000628	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTT1—kidney cancer	4.39e-05	0.000628	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.39e-05	0.000628	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IFNA2—kidney cancer	4.38e-05	0.000626	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—SLC5A5—kidney cancer	4.36e-05	0.000623	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PTGS2—kidney cancer	4.33e-05	0.000619	CbGpPWpGaD
Tenofovir—ABCC4—Ectoderm Differentiation—MYC—kidney cancer	4.31e-05	0.000615	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	4.29e-05	0.000613	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—kidney cancer	4.29e-05	0.000613	CbGpPWpGaD
Tenofovir—CYP1A2—Arachidonic acid metabolism—PTGS2—kidney cancer	4.24e-05	0.000605	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—RAF1—kidney cancer	4.21e-05	0.000602	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.21e-05	0.000602	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—kidney cancer	4.2e-05	0.0006	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ABCB1—kidney cancer	4.16e-05	0.000594	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—PTGS1—kidney cancer	4.11e-05	0.000588	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—kidney cancer	4.08e-05	0.000584	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GSTM1—kidney cancer	4.04e-05	0.000577	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IGF2—kidney cancer	3.95e-05	0.000564	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CYP1A1—kidney cancer	3.83e-05	0.000547	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.79e-05	0.000542	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PTEN—kidney cancer	3.78e-05	0.00054	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—IL2—kidney cancer	3.78e-05	0.00054	CbGpPWpGaD
Tenofovir—NME2—Metabolism—POMC—kidney cancer	3.77e-05	0.000538	CbGpPWpGaD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—POMC—kidney cancer	3.72e-05	0.000532	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.68e-05	0.000525	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.66e-05	0.000524	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	3.63e-05	0.000519	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	3.57e-05	0.00051	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.55e-05	0.000507	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.47e-05	0.000495	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.32e-05	0.000475	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	3.28e-05	0.000469	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	3.21e-05	0.000459	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	3.21e-05	0.000459	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTP1—kidney cancer	3.04e-05	0.000435	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	3.04e-05	0.000434	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	3.03e-05	0.000433	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PTGS2—kidney cancer	3e-05	0.000429	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	3e-05	0.000429	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.89e-05	0.000414	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	2.89e-05	0.000413	CbGpPWpGaD
Tenofovir—NME1—Metabolism—POMC—kidney cancer	2.85e-05	0.000408	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.8e-05	0.000401	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTM1—kidney cancer	2.8e-05	0.0004	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	2.76e-05	0.000394	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PIK3CA—kidney cancer	2.67e-05	0.000381	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	2.65e-05	0.000379	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PTEN—kidney cancer	2.62e-05	0.000374	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	2.62e-05	0.000374	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	2.51e-05	0.000358	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ACY1—kidney cancer	2.33e-05	0.000333	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PTGS2—kidney cancer	2.28e-05	0.000325	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—RAF1—kidney cancer	2.17e-05	0.00031	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.99e-05	0.000284	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PTEN—kidney cancer	1.99e-05	0.000284	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PDHB—kidney cancer	1.98e-05	0.000283	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—POMC—kidney cancer	1.98e-05	0.000283	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—RAF1—kidney cancer	1.96e-05	0.00028	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—IL2—kidney cancer	1.95e-05	0.000278	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—RAF1—kidney cancer	1.88e-05	0.000269	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CCBL1—kidney cancer	1.86e-05	0.000266	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PIK3CA—kidney cancer	1.85e-05	0.000264	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.69e-05	0.000241	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—VEGFA—kidney cancer	1.66e-05	0.000237	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	1.64e-05	0.000234	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GLIPR1—kidney cancer	1.62e-05	0.000231	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PPAT—kidney cancer	1.62e-05	0.000231	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.6e-05	0.000228	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.59e-05	0.000227	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.58e-05	0.000226	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—MAPK3—kidney cancer	1.57e-05	0.000224	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—APRT—kidney cancer	1.5e-05	0.000215	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—FH—kidney cancer	1.5e-05	0.000215	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—MAPK1—kidney cancer	1.49e-05	0.000213	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.47e-05	0.00021	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GPC3—kidney cancer	1.41e-05	0.000202	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—KRAS—kidney cancer	1.41e-05	0.000201	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PIK3CA—kidney cancer	1.4e-05	0.0002	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CA2—kidney cancer	1.37e-05	0.000196	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ALAD—kidney cancer	1.34e-05	0.000191	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.31e-05	0.000187	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—PIK3CA—kidney cancer	1.29e-05	0.000185	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.28e-05	0.000183	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TP53—kidney cancer	1.25e-05	0.000179	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PGK1—kidney cancer	1.23e-05	0.000175	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.23e-05	0.000175	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—LDHB—kidney cancer	1.2e-05	0.000172	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CA9—kidney cancer	1.04e-05	0.000149	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.02e-05	0.000146	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CRABP1—kidney cancer	8.86e-06	0.000127	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ITPR2—kidney cancer	8.24e-06	0.000118	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.59e-06	0.000108	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTT1—kidney cancer	7.51e-06	0.000107	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ACHE—kidney cancer	7.51e-06	0.000107	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SCARB1—kidney cancer	7.11e-06	0.000102	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PTGS1—kidney cancer	7.04e-06	0.000101	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PSMD7—kidney cancer	6.9e-06	9.86e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—BCHE—kidney cancer	6.54e-06	9.35e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SLC5A5—kidney cancer	6.46e-06	9.23e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—SLC2A1—kidney cancer	6.24e-06	8.92e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.06e-06	8.65e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.28e-06	7.55e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTP1—kidney cancer	5.21e-06	7.44e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ABCB1—kidney cancer	4.93e-06	7.04e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTM1—kidney cancer	4.78e-06	6.84e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP1A1—kidney cancer	4.53e-06	6.48e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.73e-06	5.32e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—POMC—kidney cancer	3.38e-06	4.83e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PTGS2—kidney cancer	2.7e-06	3.85e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PTEN—kidney cancer	2.35e-06	3.36e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.66e-06	2.37e-05	CbGpPWpGaD
